| Course | DNP 820 Translational Research and Evidence-Based Practice |
|---|---|
| Topic | Topic 3 |
| Paper type | Evidence appraisal comparison |
| Length | About 1,230 words, 3 pages |
| Format | APA 7 student paper |
| School | Grand Canyon University (GCU) |
| Program | DNP |
| Updated | October 2026 |
Free sample paper for DNP 820 Topic 3
One Trial, Two Appraisal Tools: The Awakening and Breathing Controlled Trial Under RoB 2 and the Johns Hopkins Research Evidence Appraisal Tool
[Author Name]
College of Nursing and Health Care Professions, Grand Canyon University
DNP-820: Translational Research and Evidence-Based Practice
Topic 3 Assignment
[Instructor Name]
June 21, 2027
The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.
One Trial, Two Appraisal Tools: The Awakening and Breathing Controlled Trial Under RoB 2 and the Johns Hopkins Research Evidence Appraisal Tool
The Study and the Question It Is Appraised Against
The study is the Awakening and Breathing Controlled trial (Girard et al., 2008), in which 336 ventilated patients at four academic centers were allocated either to the paired protocol, with sedation stopped each morning and a breathing trial run after a passed awakening screen, or to a control arm whose sedation followed usual practice while breathing trials still ran every day. The primary outcome was time breathing without assistance over 28 days. The question it is appraised against comes from the project in the composite medical ICU: if this ICU raises the proportion of eligible days with paired trials, can it expect patients to come off the ventilator sooner? That question matters for appraisal, because it determines which flaws count. A flaw that threatens the estimate of days breathing without assistance matters a great deal here; a flaw affecting only one-year mortality matters less, since the project will not be judged on it.
The First Instrument: RoB 2, Domain by Domain
The revised Cochrane risk-of-bias tool for randomized trials, RoB 2, assesses five domains, each reached through signaling questions, and produces a judgment of low risk, some concerns or high risk for each domain and overall (Sterne et al., 2019). Applied to this trial for the primary outcome, the judgments were as follows.
Bias arising from the randomization process: low risk. I judged this from the methods as reported, which describe random assignment of individual patients and show similar groups at baseline. Bias due to deviations from intended interventions: some concerns. The trial was unblinded, as it had to be, since clinicians cannot be blinded to whether sedation is stopped. Clinicians who knew the allocation also made the decisions that ended ventilation, and the primary outcome depends on those decisions. Seven control patients discontinued their assigned protocol. Bias due to missing outcome data: low risk. Three patients were lost to follow-up in total, one in the intervention group and two in the control group. Bias in measurement of the outcome: some concerns. Days breathing without assistance is recorded from ventilator status rather than rated by an assessor, which limits the room for bias, but extubation and reintubation are clinical judgments made by people aware of the allocation. Bias in selection of the reported result: low risk, since the trial was registered with a stated primary endpoint that matches the one reported. Overall, the trial receives some concerns for the primary outcome, driven by domains 2 and 4.
The Second Instrument: The Johns Hopkins Research Evidence Appraisal Tool
The Johns Hopkins model's research evidence appraisal tool first assigns a level based on design and then a quality rating of high, good or low, reached through a set of appraisal questions and an overall judgment (Dang et al., 2022). Applied to the same trial, the level is straightforward: a randomized controlled trial is Level I. The appraisal questions ask, among other things, whether participants were randomized, whether a control group was used, whether the sample was sufficient, whether results were consistent and whether conclusions follow from the findings. The trial answers yes to most of them. It asks whether the study was blinded, and the answer is no, which is recorded. The quality rating is then a global judgment across all the answers, and on that basis the trial rates as high or good quality. I rated it good rather than high because of the unblinded design and the self-extubation signal, but the tool gave me no instruction on how much either should count.
Where the Two Verdicts Disagree
The two instruments agree on design. Both identify a multicenter randomized trial with a clear primary outcome, low attrition and a result that favors the intervention. They disagree on the weight of one feature: the unblinded assessment of an outcome that depends on clinicians' decisions. RoB 2 treats it as a specific threat to the estimate, locates it in two domains and carries it into the overall judgment, so the trial cannot reach low risk for this outcome however well it was otherwise conducted. The Johns Hopkins tool records the absence of blinding as one answer among many and then asks for a global quality rating, so the same fact can pull the rating down slightly, heavily or not at all, depending on the appraiser.
The disagreement matters for this question. If clinicians who knew a patient had passed an awakening trial were quicker to extubate, some of the 3.1-day difference could reflect behavior rather than physiology. The trial offers partial reassurance: reintubation rates were similar in the two groups (13.8 vs. 12.5 percent), which argues against extubation decisions being made carelessly in the intervention group (Girard et al., 2008). That reassurance is exactly the kind of evidence RoB 2's signaling questions push an appraiser to look for, and the Johns Hopkins tool does not.
What the Disagreement Reveals About Instruments and the Hierarchy
An appraisal instrument is a set of prior judgments about which flaws matter. RoB 2 was built around the ways a randomized trial's estimate can be biased, so it weights those threats explicitly and ignores features, such as generalizability, that do not bias the estimate. The Johns Hopkins tool was built for teams appraising mixed bodies of evidence for practice change, so it asks broader questions and leaves the weighting to the team. Neither approach is wrong. They answer different questions: how far to trust this estimate, and how useful is this study to a practice decision.
The evidence hierarchy has the same limit. Level alone would place this trial above the ICU Liberation Collaborative cohort, which followed 15,226 adults across 68 ICUs and reported that each step up in the share of eligible elements delivered came with a further drop in the odds of still being ventilated the next day (Pun et al., 2019). For this project's question, the cohort is in some respects more useful, because it describes what happens when the practice is performed at varying levels in routine care, which is exactly the situation the ICU is in. A small, poorly conducted trial would still outrank that cohort on level. The level tells the appraiser what the design can support in principle; it says nothing about how well a given study was done.
The Instrument Chosen for This Body of Literature
The literature the project will appraise is mostly nonrandomized. The search built in Topic 2 retrieved 35 records, and the studies most relevant to raising adherence are single-site before-and-after projects and collaborative cohorts, with only a few trials. RoB 2 cannot be applied to most of them. I will therefore use the Johns Hopkins research and nonresearch appraisal tools across the whole body, so every source is rated on a common scale, and I will supplement them with one explicit rule: for any study whose outcome depends on unblinded clinical decisions, the appraisal note must state what the study offers to check for that bias, as the reintubation rates did here. For the few randomized trials, I will also complete RoB 2 domains 2 and 4 and record them alongside the Johns Hopkins rating. The choice is defended on the study types in the body of evidence, not on familiarity with either tool.
References
Dang, D., Dearholt, S. L., Bissett, K., Ascenzi, J., & Whalen, M. (2022). Johns Hopkins evidence-based practice for nurses and healthcare professionals: Model and guidelines (4th ed.). Sigma Theta Tau International.
Girard, T. D., Kress, J. P., Fuchs, B. D., Thomason, J. W. W., Schweickert, W. D., Pun, B. T., Taichman, D. B., Dunn, J. G., Pohlman, A. S., Kinniry, P. A., Jackson, J. C., Canonico, A. E., Light, R. W., Shintani, A. K., Thompson, J. L., Gordon, S. M., Hall, J. B., Dittus, R. S., Bernard, G. R., & Ely, E. W. (2008). Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): A randomised controlled trial. The Lancet, 371(9607), 126-134. https://doi.org/10.1016/S0140-6736(08)60105-1
Pun, B. T., Balas, M. C., Barnes-Daly, M. A., Thompson, J. L., Aldrich, J. M., Barr, J., Byrum, D., Carson, S. S., Devlin, J. W., Engel, H. J., Esbrook, C. L., Hargett, K. D., Harmon, L., Hielsberg, C., Jackson, J. C., Kelly, T. L., Kumar, V., Millner, L., Morse, A., . . . Ely, E. W. (2019). Caring for critically ill patients with the ABCDEF bundle: Results of the ICU Liberation Collaborative in over 15,000 adults. Critical Care Medicine, 47(1), 3-14. https://doi.org/10.1097/CCM.0000000000003482
Sterne, J. A. C., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., Cates, C. J., Cheng, H. Y., Corbett, M. S., Eldridge, S. M., Emberson, J. R., Hernán, M. A., Hopewell, S., Hróbjartsson, A., Junqueira, D. R., Jüni, P., Kirkham, J. J., Lasserson, T., Li, T., . . . Higgins, J. P. T. (2019). RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ, 366, Article l4898. https://doi.org/10.1136/bmj.l4898
What the DNP 820 Topic 3 instructions ask for
Topic 3 in DNP-820 asks students to appraise evidence using a recognized instrument. Strong papers state the study and the question it is appraised against, then apply the instrument item by item or domain by domain rather than giving a single score. Students may compare two instruments on the same study to show what each weighs, explain where their verdicts disagree and why, and consider what this reveals about the evidence hierarchy. The paper should choose an instrument for the body of literature the project will actually appraise, which for practice projects is often largely nonrandomized. A table of domains and judgments for each instrument helps faculty follow the comparison, and the paper should quote signaling questions where they decide a judgment.
How the DNP-820 Topic 3 example is put together
The finished example runs one study through two appraisal instruments and reports the results side by side. The tools agree about the design and disagree about the weight of an unblinded outcome assessment, which one treats as a serious threat and the other records without weighting. That disagreement is where the paper spends its length, because it exposes what an appraisal tool actually is, which is a set of judgments about which flaws matter. The hierarchy of evidence is handled in the same spirit: a well conducted cohort study is shown to be more useful for this question than a badly conducted trial, which the level alone would not reveal. The example concludes with a defended choice of instrument.
DNP 820 Topic 3 rubric: what Excellent looks like
Faculty reward an instrument applied domain by domain. An Excellent paper appraises Girard and colleagues' trial under RoB 2's five domains with signaling questions, then under the Johns Hopkins level and quality ratings. Credit goes to identifying where the verdicts diverge, such as unblinded clinicians and protocol deviations. The rubric values explaining that each instrument encodes prior judgments about which flaws matter, with Sterne and colleagues and Dang and colleagues as sources. Strong papers report domains, not totals. Top marks go to choosing an instrument for the 35 mostly nonrandomized records.
DNP 820 Topic 3 help: mistakes that cost marks
The weakest submissions describe appraisal instruments without applying any of them, which turns the topic into a summary of what is already in the reading. A second failure is reporting a total score with no domains behind it, since two studies can reach the same score through entirely different weaknesses. Marks also go for treating the evidence hierarchy as decisive, when design level says nothing about how well a study was conducted. Appraisals performed with no question in mind have no standard to judge against. Papers that find the two tools in perfect agreement have usually applied the second one carelessly. Choices of instrument offered with no reason read as familiarity.
Get a DNP-820 Topic 3 example written to your instructions
Send the DNP-820 Topic 3 instructions and the rubric your classroom posts, with the instruments and study your section assigned. We write a custom example to those criteria, appraising one study with two tools, reporting domains rather than totals and resolving the disagreement, in 24 to 48 hours. The first is free.
More DNP 820 papers and DNP samples
- DNP 820 Topic 1: Translation Science Orientation
- DNP 820 Topic 2: Searchable Question Construction
- DNP 820 Topic 4: DNP-820 Topic 4: Sample Paper, in Real Form
- DNP 820 Topic 5: Strength of Recommendation DQ Pair
- DNP 820 Topic 6: Synthesis Arguing a Gap
- DNP 820 Topic 7: Translation Model Selection
- DNP 820 Topic 8: Dissemination Audience Plan
- DNP 825 Topic 3: Access Barrier Analysis
- DNP 815A Topic 3: Nursing Theory Selection
- DNP 830 Topic 3: Sampling and Probability Write-up
- DNP 810 Topic 3: Genetic Testing Disclosure Case
DNP 820 Topic 3 questions, answered
Why appraise the same study twice?
Because it shows what an appraisal instrument is. Tools embody judgments about which flaws matter, and those judgments differ. Watching two respected instruments reach different conclusions about the same paper is the fastest way to understand that appraisal is reasoning rather than scoring, which is exactly what the topic is trying to teach at doctoral level.
Is a higher level of evidence always better?
No, and treating it that way causes real errors. A poorly conducted trial with substantial loss to follow up can be less trustworthy than a large, careful cohort study. Design level tells you what a study could establish if done well; appraisal tells you whether it was. Papers that stop at the level have done half of the work.
Should I report scores or domains?
Domains, always, and a total only if the instrument requires one. A score of six conceals whether the losses came from randomization, blinding or attrition, and those have different consequences for how much you trust the finding. Reporting domain by domain also lets a reader disagree with your judgment on one point without discarding the whole appraisal.
Where can I find a free DNP 820 Topic 3 sample paper?
The appraisal comparison for DNP 820 Topic 3 covers the study and question, RoB 2 domain by domain, the Johns Hopkins appraisal tool, where the verdicts disagree, what that reveals and the instrument chosen for this literature. Post your DNP 820 Topic 3 prompt and get a free appraisal.
Why appraise one trial twice in DNP 820 Topic 3?
It shows what each instrument is built to notice. RoB 2 weights the ways a randomized estimate can be biased, while the Johns Hopkins tool rates design level and overall quality for mixed evidence.